Kinloch Capital LLC trimmed its stake in The Clorox Company (NYSE:CLX – Free Report) by 31.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 17,483 shares of the company’s stock after selling 7,956 shares during the period. Kinloch Capital LLC’s holdings in Clorox were worth $1,763,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently made changes to their positions in CLX. Haverford Trust Co boosted its stake in shares of Clorox by 2.8% in the 4th quarter. Haverford Trust Co now owns 3,070 shares of the company’s stock valued at $310,000 after purchasing an additional 84 shares in the last quarter. Field & Main Bank lifted its holdings in Clorox by 3.3% during the 4th quarter. Field & Main Bank now owns 3,100 shares of the company’s stock valued at $313,000 after purchasing an additional 100 shares during the last quarter. Golden State Wealth Management LLC boosted its position in Clorox by 28.2% in the fourth quarter. Golden State Wealth Management LLC now owns 454 shares of the company’s stock valued at $46,000 after buying an additional 100 shares in the last quarter. Fisher Asset Management LLC boosted its position in Clorox by 1.7% in the third quarter. Fisher Asset Management LLC now owns 6,053 shares of the company’s stock valued at $746,000 after buying an additional 102 shares in the last quarter. Finally, Johnson Financial Group Inc. grew its stake in Clorox by 3.1% during the third quarter. Johnson Financial Group Inc. now owns 3,659 shares of the company’s stock worth $451,000 after buying an additional 109 shares during the last quarter. 78.53% of the stock is owned by institutional investors.
Clorox Price Performance
Clorox stock opened at $95.90 on Friday. The business’s 50-day simple moving average is $95.91 and its 200 day simple moving average is $104.88. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The stock has a market cap of $11.60 billion, a price-to-earnings ratio of 15.57, a P/E/G ratio of 0.49 and a beta of 0.56. The Clorox Company has a 12-month low of $84.70 and a 12-month high of $132.03.
Wall Street Analyst Weigh In
A number of research analysts have recently issued reports on the stock. Jefferies Financial Group cut their target price on shares of Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a research note on Monday, May 4th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $91.00 price objective on shares of Clorox in a research report on Friday, May 1st. Weiss Ratings upgraded Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, April 13th. Evercore restated an “underperform” rating and issued a $110.00 target price on shares of Clorox in a research note on Friday, May 1st. Finally, Citigroup decreased their price objective on shares of Clorox from $110.00 to $97.00 and set a “neutral” rating on the stock in a report on Friday, May 1st. One investment analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have issued a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Reduce” and a consensus price target of $103.40.
Check Out Our Latest Stock Analysis on Clorox
Insider Activity at Clorox
In other Clorox news, Director Pierre R. Breber purchased 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 5th. The stock was acquired at an average cost of $85.82 per share, with a total value of $429,100.00. Following the completion of the purchase, the director directly owned 18,000 shares in the company, valued at approximately $1,544,760. This represents a 38.46% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.63% of the stock is currently owned by corporate insiders.
Clorox Profile
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
Featured Articles
- Five stocks we like better than Clorox
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
